Tumor production of angiostatin is enhanced after exposure to TNF-α

International Journal of Cancer

Volumn 97, Issue 4, 2002, Pages 410-415

  Mauceri, Helena J ^a   Seetharam, Saraswathy ^a   Beckett, Michael A ^a   Lee, John Y ^a   Gupta, Vinay K ^a   Gately, Stephen ^b   Stack, M Sharon ^b   Brown, Charles K ^a   Swedberg, Kirsten ^a   Kufe, Donald W ^c   Weichselbaum, Ralph R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adenoviral gene therapy; Angiostatin; MMPs; Plasminogen activator

Indexed keywords

ANGIOSTATIN; ANTICOAGULANT AGENT; GELATINASE B; PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; EXPRESSION VECTOR; FEMALE; GENE THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; THROMBOSIS; TREATMENT OUTCOME;

ADENOCARCINOMA; ADENOVIRIDAE; ANGIOSTATINS; ANIMALS; CARCINOMA, SQUAMOUS CELL; CULTURE MEDIA, CONDITIONED; DEFECTIVE VIRUSES; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PLASMINOGEN; PLASMINOGEN ACTIVATORS; PROSTATIC NEOPLASMS; PROTEASE INHIBITORS; RECOMBINANT FUSION PROTEINS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036466852     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1629     Document Type: Article

References (40)

1. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level
2. Toxic effect of tumor necrosis factor on tumor vasculature in mice
3. A novel domain within the 55 Kd TNF receptor signals cell death
4. Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNF alpha)
5. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice
6. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro
7. Restoration of E2F expression rescues vascular endothelial cells from tumor necrosis factor-alpha-induced apoptosis
8. Recombinant human tumor necrosis factor-alpha: Thrombus formation is a cause of antitumor activity
9. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas
10. The effects of turnout necrosis factor alpha on the vascular bed and blood flow in an experimental rat hepatoma
11. The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent and limited by severe toxicity
12. A phase I trial of recombinant human tumor necrosis factor and interferon-gamma: Effects of combination cytokine administration in vivo
13. Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy
14. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells
15. Spatial and temporal control of gene therapy using ionizing radiation
16. Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature
17. The mechanism of cancermediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
18. Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells
19. Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin
20. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma
21. Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor
22. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
23. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3)
24. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance
25. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/Type IV collagenase (MMP-9)
26. Combined effects of angiostatin and ionizing radiation in antitumor therapy
27. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas
28. Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from the laminin A chain
29. Increased injection number enhances adenoviral genetic radiotherapy
30. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin
31. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen
32. Effects of tumour necrosis factor-alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases
33. TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts
34. Complex role of matrix metalloproteinases in angiogenesis
35. Shedding of the lymphocyte L-selectin adhesion molecule is inhibited by a hydroxamic acid-based protease inhibitor. Identification with an L-selectin-alkaline phosphatase reporter
36. Ionizing radiation activates transcription of the EGR1 gene via CArG elements
37. Angiogenic balance in human melanoma: Expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo
38. Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha
39. Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-alpha (TNF-alpha) in NB4 leukemic cells: Specific involvement of TNF receptor type 1
40. Phosphoglycerate kinase acts in tumour angiogenesis as a disulfide reductase